{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:29:42Z","timestamp":1649006982721},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T00:00:00Z","timestamp":1489708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00280-017-3280-2","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T21:09:31Z","timestamp":1489784971000},"page":"791-800","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies"],"prefix":"10.1007","volume":"79","author":[{"given":"Tianxin","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"3280_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","volume":"893","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Jemal A (2016) Lung cancer statistics. Adv Exp Med Biol 893:1\u201319. doi: 10.1007\/978-3-319-24223-1_1","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3280_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3978\/j.issn.2218-6751.2016.01.03","volume":"5","author":"F Koinis","year":"2016","unstructured":"Koinis F, Kotsakis A, Georgoulias V (2016) Small cell lung cancer (SCLC): no treatment advances in recent years. Transl Lung Cancer Res 5(1):39\u201350. doi: 10.3978\/j.issn.2218-6751.2016.01.03","journal-title":"Transl Lung Cancer Res"},{"key":"3280_CR3","doi-asserted-by":"publisher","first-page":"CD006849","DOI":"10.1002\/14651858.CD006849.pub3","volume":"8","author":"IU Amarasena","year":"2015","unstructured":"Amarasena IU, Chatterjee S, Walters JA, Wood-Baker R, Fong KM (2015) Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev 8:CD006849. doi: 10.1002\/14651858.CD006849.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3280_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.lungcan.2013.06.022","volume":"81","author":"F Petrelli","year":"2013","unstructured":"Petrelli F, Coinu A, Cabiddu M, Ghilardi M, Ardine M, Barni S (2013) Platinum rechallenge in patients with advanced NSCLC: a pooled analysis. Lung cancer 81(3):337\u2013342. doi: 10.1016\/j.lungcan.2013.06.022","journal-title":"Lung cancer"},{"issue":"10","key":"3280_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jgg.2015.08.005","volume":"42","author":"R Wei","year":"2015","unstructured":"Wei R, DeVilbiss FT, Liu W (2015) Genetic polymorphism, telomere biology and non-small lung cancer risk. J Genet Genom Yi chuan xue bao 42(10):549\u2013561. doi: 10.1016\/j.jgg.2015.08.005","journal-title":"J Genet Genom Yi chuan xue bao"},{"issue":"4","key":"3280_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1590\/S1679-45082014RB2906","volume":"12","author":"RA Mello de","year":"2014","unstructured":"de Mello RA (2014) Genetic polymorphisms and non-small-cell lung cancer: future paradigms. Einstein 12 (4):524\u2013526. doi: 10.1590\/S1679-45082014RB2906","journal-title":"Einstein"},{"issue":"2","key":"3280_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2014.01.005","volume":"346","author":"NA Bowden","year":"2014","unstructured":"Bowden NA (2014) Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy? Cancer Lett 346(2):163\u2013171. doi: 10.1016\/j.canlet.2014.01.005","journal-title":"Cancer Lett"},{"issue":"8","key":"3280_CR8","doi-asserted-by":"publisher","first-page":"e72251","DOI":"10.1371\/journal.pone.0072251","volume":"8","author":"M Qiu","year":"2013","unstructured":"Qiu M, Yang X, Hu J, Ding X, Jiang F, Yin R, Xu L (2013) Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis. PloS one 8(8):e72251. doi: 10.1371\/journal.pone.0072251","journal-title":"PloS one"},{"issue":"4","key":"3280_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/aje\/kwj189","volume":"164","author":"M Manuguerra","year":"2006","unstructured":"Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G (2006) XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164(4):297\u2013302. doi: 10.1093\/aje\/kwj189","journal-title":"Am J Epidemiol"},{"issue":"6425","key":"3280_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/363182a0","volume":"363","author":"D Scherly","year":"1993","unstructured":"Scherly D, Nouspikel T, Corlet J, Ucla C, Bairoch A, Clarkson SG (1993) Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 363(6425):182\u2013185. doi: 10.1038\/363182a0","journal-title":"Nature"},{"issue":"3","key":"3280_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/CAD.0b013e32835bd6ce","volume":"24","author":"C He","year":"2013","unstructured":"He C, Duan Z, Li P, Xu Q, Yuan Y (2013) Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer. Anticancer Drugs 24(3):300\u2013305. doi: 10.1097\/CAD.0b013e32835bd6ce","journal-title":"Anticancer Drugs"},{"issue":"1","key":"3280_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0921-8777(00)00071-9","volume":"485","author":"PC Hanawalt","year":"2001","unstructured":"Hanawalt PC (2001) Controlling the efficiency of excision repair. Mutat Res 485(1):3\u201313","journal-title":"Mutat Res"},{"issue":"6","key":"3280_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1046\/j.1523-1747.2002.01782.x","volume":"118","author":"S Emmert","year":"2002","unstructured":"Emmert S, Slor H, Busch DB, Batko S, Albert RB, Coleman D, Khan SG, Abu-Libdeh B, DiGiovanna JJ, Cunningham BB, Lee MM, Crollick J, Inui H, Ueda T, Hedayati M, Grossman L, Shahlavi T, Cleaver JE, Kraemer KH (2002) Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 118(6):972\u2013982. doi: 10.1046\/j.1523-1747.2002.01782.x","journal-title":"J Invest Dermatol"},{"issue":"18","key":"3280_CR14","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1089\/ars.2012.5036","volume":"18","author":"JP Melis","year":"2013","unstructured":"Melis JP, van Steeg H, Luijten M (2013) Oxidative DNA damage and nucleotide excision repair. Antioxid Redox Signal 18(18):2409\u20132419. doi: 10.1089\/ars.2012.5036","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"3280_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.molcel.2007.03.013","volume":"26","author":"S Ito","year":"2007","unstructured":"Ito S, Kuraoka I, Chymkowitch P, Compe E, Takedachi A, Ishigami C, Coin F, Egly JM, Tanaka K (2007) XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G\/CS patients. Mol Cell 26(2):231\u2013243. doi: 10.1016\/j.molcel.2007.03.013","journal-title":"Mol Cell"},{"issue":"2","key":"3280_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.dnarep.2007.10.007","volume":"7","author":"OD Scharer","year":"2008","unstructured":"Scharer OD (2008) Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG. DNA Repair 7 (2):339\u2013344. doi: 10.1016\/j.dnarep.2007.10.007","journal-title":"DNA Repair"},{"issue":"1","key":"3280_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1097-2765(00)80172-0","volume":"3","author":"A Klungland","year":"1999","unstructured":"Klungland A, Hoss M, Gunz D, Constantinou A, Clarkson SG, Doetsch PW, Bolton PH, Wood RD, Lindahl T (1999) Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell 3(1):33\u201342","journal-title":"Mol Cell"},{"issue":"5","key":"3280_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.acuro.2012.04.007","volume":"37","author":"H Wen","year":"2013","unstructured":"Wen H, Feng CC, Fang ZJ, Xia GW, Jiang HW, Xu G, Huang XD, Ding Q (2013) Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers. Actas Urol Esp 37(5):259\u2013265. doi: 10.1016\/j.acuro.2012.04.007","journal-title":"Actas Urol Esp"},{"issue":"4","key":"3280_CR19","doi-asserted-by":"publisher","first-page":"e61469","DOI":"10.1371\/journal.pone.0061469","volume":"8","author":"AA Negandhi","year":"2013","unstructured":"Negandhi AA, Hyde A, Dicks E, Pollett W, Younghusband BH, Parfrey P, Green RC, Savas S (2013) MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland. PloS One 8(4):e61469. doi: 10.1371\/journal.pone.0061469","journal-title":"PloS One"},{"issue":"2","key":"3280_CR20","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4238\/2014.April.17.6","volume":"13","author":"D Liu","year":"2014","unstructured":"Liu D, Wu J, Shi GY, Zhou HF, Yu Y (2014) Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer. Genet Mol Res GMR 13 (2):3100\u20133107. doi: 10.4238\/2014.April.17.6","journal-title":"Genet Mol Res GMR"},{"key":"3280_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. doi: 10.1186\/1745-6215-8-16","journal-title":"Trials"},{"issue":"22","key":"3280_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ijc.10870","volume":"3","author":"Q Yu","year":"2007","unstructured":"Yu Q, Han J, Pan J, Sheng L, Wu J, Huang H (2007) The relationship between the polymorphisms of gene XPG and MDR1 and the responsiveness of advanced non-sma ll cell lung cancer to platinum-based chem otherapy. Practical Journal of Cancer 3(22):252\u2013256. doi: 10.1002\/ijc.10870 (Article Chinese)","journal-title":"Practical Journal of Cancer"},{"issue":"19","key":"3280_CR23","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/hmg\/ddm190","volume":"16","author":"A Matakidou","year":"2007","unstructured":"Matakidou A, el Galta R, Webb EL, Rudd MF, Bridle H, Consortium G, Eisen T, Houlston RS (2007) Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet 16(19):2333\u20132340. doi: 10.1093\/hmg\/ddm190","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3280_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.lungcan.2008.11.014","volume":"65","author":"X Sun","year":"2009","unstructured":"Sun X, Li F, Sun N, Shukui Q, Baoan C, Jifeng F, Lu C, Zuhong L, Hongyan C, YuanDong C, Jiazhong J, Yingfeng Z (2009) Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients. Lung cancer 65(2):230\u2013236. doi: 10.1016\/j.lungcan.2008.11.014","journal-title":"Lung cancer"},{"issue":"5","key":"3280_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/abbs\/gmp027","volume":"41","author":"J Feng","year":"2009","unstructured":"Feng J, Sun X, Sun N, Qin S, Li F, Cheng H, Chen B, Cao Y, Ma J, Cheng L, Lu Z, Ji J, Zhou Y (2009) XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai) 41(5):429\u2013435","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"8","key":"3280_CR26","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1007\/s11033-010-0674-1","volume":"38","author":"D Butkiewicz","year":"2011","unstructured":"Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M (2011) An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep 38(8):5231\u20135241. doi: 10.1007\/s11033-010-0674-1","journal-title":"Mol Biol Rep"},{"issue":"11","key":"3280_CR27","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1097\/FPC.0b013e3280115e63","volume":"9","author":"XF Jia","year":"2011","unstructured":"Jia XF, Liang J, Lv HY, Yao RY, Zhou F, Han Y (2011) Relationship between XPA and XPG polymorphisms and platinum-based chemotherapy outcomes in advanced non-small cell lung cancer. Progress Modern Biomed 9 (11):1718\u20131722. doi: 10.1097\/FPC.0b013e3280115e63 . Article in Chinese.","journal-title":"Progress Modern Biomed"},{"issue":"22","key":"3280_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/hmg\/ddm351","volume":"8","author":"HY Lv","year":"2012","unstructured":"Lv HY, Li QC, Wei HJ, Xiang JY, Yao RY, Liang J (2012) Relationship between GSTP1 and XPG genetic polymorphisms and survival of platinum-based chemotherapy in advanced non-small cell lung cancer patients. China Int Soc Cell 8(22):609\u2013615. doi: 10.1093\/hmg\/ddm351 (Article Chinese).","journal-title":"Int Soc Cell"},{"issue":"2","key":"3280_CR29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7314\/APJCP.2013.14.2.701","volume":"14","author":"T Zhang","year":"2013","unstructured":"Zhang T, Sun J, Lv M, Zhang L, Wang X, Ren JC, Wang B (2013) XPG is predictive gene of clinical outcome in advanced non-small-cell lung cancer with platinum drug therapy. Asian Pacific J Cancer Prev APJCP 14 (2):701\u2013705","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"issue":"3","key":"3280_CR30","first-page":"762","volume":"29","author":"Y Yuli","year":"2013","unstructured":"Yuli Y, Zhe S, Xia W, Siqing L, Zhenxuan W, Yu-Hua Z, Bing S, Jun-Wei C (2013) XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer. Pak J Med Sci 29(3):762\u2013767","journal-title":"Pak J Med Sci"},{"issue":"3","key":"3280_CR31","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.4238\/2014.March.31.13","volume":"13","author":"ZY Jin","year":"2014","unstructured":"Jin ZY, Zhao XT, Zhang LN, Wang Y, Yue WT, Xu SF (2014) Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer. Genet Mol Res GMR 13 (3):7617\u20137625. doi: 10.4238\/2014.March.31.13","journal-title":"Genet Mol Res GMR"},{"issue":"2","key":"3280_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.07.023","volume":"353","author":"I Sullivan","year":"2014","unstructured":"Sullivan I, Salazar J, Majem M, Pallares C, Del Rio E, Paez D, Baiget M, Barnadas A (2014) Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Lett 353(2):160\u2013166. doi: 10.1016\/j.canlet.2014.07.023","journal-title":"Cancer Lett"},{"issue":"6","key":"3280_CR33","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1007\/s13277-014-1732-4","volume":"35","author":"W Hu","year":"2014","unstructured":"Hu W, Pan J, Zhao P, Yang G, Yang S (2014) Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer. Tumour Biol J Int Soc Oncodev Biol Med 35(6):5561\u20135567. doi: 10.1007\/s13277-014-1732-4","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"issue":"4","key":"3280_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3892\/br.2014.282","volume":"2","author":"D Huang","year":"2014","unstructured":"Huang D, Zhou Y (2014) Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: a meta-analysis based on 44 studies. Biomed Rep 2(4):452\u2013462. doi: 10.3892\/br.2014.282","journal-title":"Biomed Rep"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:53:03Z","timestamp":1498395183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3280"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3280-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}